XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Indian shares set to open higher



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares set to open higher</title></head><body>

BENGALURU, Sept 10 (Reuters) -Indian shares are set to open higher on Tuesday, tracking a rebound in global stocks ahead of the key U.S. inflation data and the Federal Reserve's interest rate decision.

The GIFT Nifty GIFc1 was at 25,035 points, as of 08:06 a.m. IST, indicating the NSE Nifty 50 .NSEI will open above its previous close of 24,936.4.

The benchmark Nifty 50 rose for the first time in four sessions on Monday, led by gains in consumer stocks and financials. However, all the other sectors and broader small- .NIFSMCP100 and mid-caps .NIFMDCP100 logged losses.

With most segments of the markets trading at valuations above long-term averages, focus shifts to global cues, according to analysts.

"A lot will depend on the performance of global markets, particularly the U.S., given the lack of major domestic triggers," said Ajit Mishra, senior vice president of research at Religare Broking.

Wall Street equities closed higher overnight, bouncing back from a weekly drop on Friday after mixed labour market data.

Focus now shifts to the U.S. consumer price index, due on Wednesday, which is expected to show that inflation remains on the path back to the Fed's target.

The reading will be a crucial factor influencing the size of the expected Fed rate cut next week.

Most European equities also gained on Monday on the prospect of a central bank rate cut later in the week.

Asian markets opened higher on Tuesday, though concerns over China's growth outlook kept sentiment in check. MKTS/GLOB

Both foreign portfolio investors (FPI) and domestic institutional investors (DII) were net buyers on Monday, purchasing domestic shares worth 11.77 billion rupees ($140.2 million) and 17.57 billion rupees, respectively.

Among individual stocks, drug makers Zydus Lifesciences ZYDU.NS, Alkem Laboratories ALKE.NS, Cipla CIPL.NS, Biocon BION.NS, Abbott India ABOT.NS, AstraZeneca Pharma India ASTR.NS will be in focus, after India's goods and services tax council recommended a reduction in tax rates on select cancer drugs.


STOCKS TO WATCH


** Snack-making companies like Gopal Snacks GOPA.NS, Prataap Snacks PRAT.NS, Bikaji Food BIKA.NS will be in focus after GST council recommends cutting tax rate on Namkeens to 12% from 18%.

** HG Infra Engineering HGIN.NS secures a project worth 7.81 billion rupees from Ministry of Road Transport and Highways.

** Ahluwalia Contracts AHLU.NS bags two orders worth 13.07 billion rupees from Signature Global for housing projects.


($1 = 83.9600 Indian rupees)




Reporting by Bharath Rajeswaran in Bengaluru; Editing by Rashmi Aich

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.